Subscribe to RSS

DOI: 10.1590/0004-282X-ANP-2020-0219
ABO blood group system and occurrence of ischemic stroke
Sistema ABO de grupos sanguíneos e ocorrência de acidente vascular cerebral isquêmico
ABSTRACT
Background: Ischemic stroke (IS) is a multifactorial disease that presents high rates of morbimortality in Brazil. Several studies proved that there is a link between the ABO blood group system and the occurrence of thrombotic events. Nonetheless, its association with IS is not well established. Objective: For that reason, the purpose hereof was to investigate the relation between the ABO blood groups and the occurrence of IS in a Brazilian cohort of cerebrovascular diseases. Methods: Five hundred and twenty-nine subjects were included over 12 months, from which 275 presented an IS episode and 254 composed the control group. Blood samples were drawn for direct and reverse serotyping. The control and IS groups were compared regarding the traditional risk factors and the distribution of the ABO blood groups. Results: The IS group presented a higher prevalence of systemic arterial hypertension (SAH), diabetes mellitus, smoking habits, family history, cardiopathy, and sedentary lifestyle in comparison with the control group. The AB blood type prevailed among the patients (5.1 vs. 1.6%; p<0.05) and this group had more SAH cases in comparison with the O type group (92.9 vs. 67.3%; p<0.05). Conclusions: Our results suggest that the occurrence of IS is more frequent among patients of the AB blood type.
RESUMO
Antecedentes: O acidente vascular cerebral isquêmico (AVCI) é uma doença multifatorial que apresenta altas taxas de morbimortalidade no Brasil. Vários estudos provaram que existe uma ligação entre o sistema ABO de grupos sanguíneos e a ocorrência de eventos trombóticos. No entanto, sua associação com AVCI não está bem estabelecida. Objetivo: Por essa razão, o objetivo deste trabalho foi investigar a relação entre os grupos sanguíneos ABO e a ocorrência de AVCI em uma coorte brasileira de doenças cerebrovasculares. Métodos: Ao longo de 12 meses foram incluídos 529 indivíduos, dos quais 275 apresentaram um episódio de AVCI e 254 compuseram o grupo controle. Amostras de sangue foram coletadas para sorotipagem direta e reversa. Os grupos controle e AVCI foram comparados em relação aos fatores de risco tradicionais e à distribuição dos grupos sanguíneos ABO. Resultados: O grupo AVCI apresentou maior prevalência de hipertensão arterial sistêmica (HAS), diabetes mellitus, tabagismo, história familiar, cardiopatia e estilo de vida sedentário em comparação ao grupo controle. O tipo sanguíneo AB prevaleceu entre os pacientes (5,1 vs. 1,6%; p<0,05) e apresentou mais casos de HAS em comparação ao tipo O (92,9 vs. 67,3%; p<0,05). Conclusões: Nossos resultados sugerem que a ocorrência de AVCI é mais frequente entre os pacientes do tipo sanguíneo AB.
Authors’ contributions:
RCL, CSW: conceived and designed the research, acquired the data, analyzed and interpreted the data and drafted the manuscript; SAR: conceived and designed the research, handled supervision, analyzed and interpreted the data; LEF, NLC: analyzed and interpreted the data and made critical revision of the manuscript for important intellectual content; PHCF: conceived and designed the research, handled supervision, analyzed and interpreted the data and made critical revision of the manuscript for important intellectual content.
Support:
This work was supported by the Research Support Fund from the Universidade da Região de Joinville (INVITATION LETTER Nº 02/16 - Call for Projects Linked to Stricto Sensu Programs).
Publication History
Received: 03 June 2020
Accepted: 11 January 2021
Article published online:
07 June 2023
© 2021. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Giles MF, Rothwell PM. Measuring the prevalence of stroke. Neuroepidemiology. 2008 Jun;30(4):205-6. https://doi.org/10.1159/000126913
- 2 Person TA, Blair SN, Daniels SR, Eckel RH, Fair JM Fortmann SP, Franklin BA, et al. AHA Guidelines for Primary Prevention of Cardiovascular disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002 Jul;106(3):388-91. https://doi.org/10.1161/01.CIR.0000020190.45892.75
- 3 Cabral NL, Longo AL, Moro CH, Amaral CH, Kiss HC. Epidemiology of cerebrovascular disease in Joinville, Brazil. An institutional study. Arq Neuro-Psiquiatr. 1997 Sep;55(3A):357-63. https://doi.org/10.1590/s0004-282x1997000300002
- 4 Minelli C, Fen LF, Minelli DPC. Stroke incidence prognosis, 30-day and a 1-year case fatality rates in Matão, Brazil: a population-based prospective study. Stroke. 2007 Nov;38(11):2906-11. https://doi.org/10.1161/STROKEAHA.107.484139
- 5 Cheng YC, Cole JW, Mitchell BD, Kittner SJ. Genetics of ischemic stroke in young adults. Circ Cardiovasc Genet. 2014 Jun;7(3):383-92. https://doi.org/10.1161/CIRCGENETICS.113.000390
- 6 Romero JR, Morris J, Pikula A. Stroke prevention: modifying risk factors. Ther Adv Cardiovasc Dis. 2008 Aug;2(4):287-303. https://doi.org/10.1177/1753944708093847
- 7 Bhatt VR, Mainali NR, Sigdel S, Aryal M, Hamal N, Khanal S, et al. Risk factors of stroke. N Engl J Med. 2006 Apr;354(16):1706-17. https://doi.org/10.1056/NEJMoa060989
- 8 Zakai NA, Judd SE, Alexander K, McClure LA, Kissela BM, Howard G, et al. ABO blood type and stroke risk: The reasons for geographic and racial differences in stroke study. J Thromb Haemost. 2014 Apr;12(4):564-70. https://doi.org/10.1111/jth.12507
- 9 Franchini M, Makris M. Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus. 2013 Apr;11(2):164-5. https://doi.org/10.2450/2012.0087-12
- 10 Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ. 2013 Mar;185(5):E229-37. https://doi.org/10.1503/cmaj.121636
- 11 Spiezia L, Campello E, Bon M, Tison T, Milan M, Simioni P, et al. ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus. 2013 Apr;11(2):250-3. https://doi.org/10.2450/2012.0060-12
- 12 Sabino A, Ribeiro DD, Domingheti CP, Rios DR, Dusse LM, Carvalho MD, et al. ABO blood group polymorphisms and risk for ischemic stroke and peripheral arterial disease. Mol Biol Rep. 2014 Mar;41(3):1771-7. https://doi.org/10.1007/s11033-014-3026-8
- 13 Williams FM, Carter AM, Hysi PG, Surdulescu G, Hodgkiss D, Soranzo N, et al. Ischemic Stroke Is Associated with the ABO Locus: The EuroCLOT Study. Ann Neurol. 2013 Jan;73(1):16-31. https://doi.org/10.1002/ana.23838
- 14 Ling X, Zheng Y, Tao J, Zheng Z, Chen L. Association study of polymorphisms in the ABO gene with ischemic stroke in the Chinese population. BMC Neurol. 2016;16(1):146. https://doi.org/10.1002/jcla.22329
- 15 Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35-41. https://doi.org/10.1161/01.str.24.1.35
- 16 Cabral NL, Cougo-Pinto PT, Magalhaes PS, Longo AL, Moro CH, Amaral CH, et al. Trends of stroke incidence from 1995 to 2013 in Joinville, Brazil. Neuroepidemiology. 2016 May;46(4):273-81. https://doi.org/10.1159/000445060
- 17 Vasan SK, Rostgaard K, Majeed A, Ullum H, Titlestad KE, Pedersen OB, et al. ABO blood group and risk of thromboembolic and arterial disease: a study of 1.5 million blood donors. Circulation. 2016 Apr;133(15):1449-57; discussion 1457. https://doi.org/10.1161/CIRCULATIONAHA.115.017563
- 18 Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, et al. Blood cholesterol and vascular mortality by age, sex and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007 Dec;370(9602):1829-39. https://doi.org/10.1016/S0140-6736(07)61778-4
- 19 Rapsomaniki E, Timmis A, George J, Pujades-Todriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014 May;383(9932):1899-911. https://doi.org/10.1016/S0140-6736(14)60685-1
- 20 Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D’Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framingham Study Am Heart J. 1996 Apr;131(4):790-5. https://doi.org/10.1016/s0002-8703(96)90288-4
- 21 Colditz GA. The Nurses’ Health Study: findings during 10 years of follow up of a cohort of U.S. women. Curr Prob Obstet Gynecol Fertil. 1990;45(11):774-5.
- 22 Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA. 1988 Feb;259(7):1025-9. https://doi.org/10.1001/jama.1988.03720070025028
- 23 Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, et al. Smoking cessation and decreased risk of stroke in women. JAMA. 1993 Jan;269(2):232-6. https://doi.org/10.1001/jama.1993.03500020066033
- 24 Novaretti M, Dorlhiac-Llacer P, Chamone D. Estudo de grupos sanguíneos em doadores de sangue caucasoides e negroides na cidade de São Paulo. Rev Bras Hematol Hemoter. 2000 Apr;22(1):23-32. https://doi.org/10.1590/S1516-8484220200219100004
- 25 Coelho E, Diniz R, Reis J, Gomes K. Frequência de grupos sanguíneos dos sistemas ABO e Rh na população de Belo Horizonte - MG. Rev Bras Anal Clin. 2010; 42(4): 245-7. https://doi.org/10.34117/bjdv6n10-324